Theravance Biopharma Inc. Stock Performance
as on July 3, 2026 at 2:15 pm IST
Day's Low
Day's High
$16.94$17.02
-0.06%
Downside
0.53%
Upside
52 Week's Low
52 Week's High
$10.82$21.0336.08%
Downside
24.22%
Upside
Theravance Biopharma Inc. share price movements today
- Previous Close
- $16.98
- Open
- $17.00
- Volume
- 1.4M
- Day's Low - High
- $16.94 - $17.02
- 52 Week Low - High
- $10.82 - $21.03
Theravance Biopharma Inc. Historical Returns
- 1 Month Return
- + 6.34 %
- 3 Month Return
- + 5.68 %
- 1 Year Return
- + 51.84 %
- 3 Year Return
- + 62.16 %
- 5 Year Return
- + 17.81 %
Theravance Biopharma Inc. Stock Fundamentals & Key Indicators
Check Theravance Biopharma Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$880.0M
EPS (TTM)
0.21
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
7.61
Industry PE ratio
-7.114069767441861
PEG Ratio
-0.05
EBITDA
6.6M
Revenue (TTM)
109.8M
Profit Margin
104.34%
Return On Equity TTM
50.17%
Theravance Biopharma Inc. Stock Valuation
Track how Theravance Biopharma Inc. P/E has moved over time to understand its valuation trends.
Theravance Biopharma Inc. in the last 5 years
Lowest (-46.33x)
March 31, 2024
Industry (-7.11x)
July 3, 2026
Today (7.61x)
July 3, 2026
Highest (66.49x)
June 30, 2026
Today’s Price to Earnings Ratio: 7.61x
Theravance Biopharma Inc. vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Theravance Biopharma Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| BUY | $880.0M | 17.81% | 7.61 | 104.34% | NA | |
| BUY | $39.9B | 478.19% | NA | 0.00% | NA | |
| BUY | $40.3B | 82.45% | 75.8 | 12.55% | NA | |
| BUY | $126.4B | 163.31% | 29.59 | 35.51% | NA | |
| BUY | $65.5B | 12.1% | 15.25 | 29.65% | 0.5700000000000001% |
Stock Returns calculator for Theravance Biopharma Inc. Stock including INR - Dollar returns
The Theravance Biopharma Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Theravance Biopharma Inc. investment value today
Current value as on today
₹1,69,072
Returns
₹69,072
(+69.07%)
Returns from Theravance Biopharma Inc. Stock
₹51,839 (+51.84%)
Dollar Impact
₹17,233 (+17.23%)
Analyst Recommendation on Theravance Biopharma Inc. Stock
Based on 11 analysts
72.73%
Buy
27.27%
Hold
0.00%
Sell
Based on 11 analysts, 72.73% of analysts recommend a 'BUY' rating for Theravance Biopharma Inc.. Average target price of $16.5
Theravance Biopharma Inc. Share Price Target
Get share price movements and forecasts by analysts on Theravance Biopharma Inc..
What analysts predicted
-2.61%DOWNSIDE
Target Price
$16.5
Current Price
$16.93
Analyzed by
11 Analysts
Target
$16.50
Theravance Biopharma Inc. target price $16.5, a slight downside of -2.61% compared to current price of $16.93. According to 11 analysts rating.
Indian Investors' Interest in Theravance Biopharma Inc. Stock
Search interest for Theravance Biopharma Inc. Stock has increased by 167% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:167% versus previous 30 day period
Theravance Biopharma Inc. Quarterly Profit & Loss
All numbers in Millions USD
Theravance Biopharma Inc. Annual Profit & Loss
All numbers in Millions USD
Theravance Biopharma Inc. Quarterly Cash Flow
All numbers in Millions USD
Theravance Biopharma Inc. Annual Cash Flow
All numbers in Millions USD
Theravance Biopharma Inc. News & Key Events
Today's Timeline - 29 June
Mon, 06:14 PM
-Zymeworks to acquire Theravance for $17 per share, totaling $929 million, with contingent value rights for shareholders.
Insights on Theravance Biopharma Inc.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTAgainst Peers
In the last 1 year, Revolution Medicines, Inc. Common Stock has given 399.7% return, outperforming this stock by 347.9%
- NO EFFECT
Against Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 604.0% return, outperforming this stock by 540.9%
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 2 quarters, 61.02M → -4.93M (in $), with an average decrease of 108.1% per quarter
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 45.89M → 17.69M (in $), with an average decrease of 61.4% per quarter
- NEGATIVE IMPACT
Price Dip
In the last 7 days, TBPH stock has moved down by -4.0%
About Theravance Biopharma Inc.
| Organisation | Theravance Biopharma Inc. |
| Headquarters | 901 Gateway Boulevard, South San Francisco, CA, United States, 94080 |
| Industry | Biotechnology |
| CEO | Mr. Rick E. Winningham M.B.A. |
| E-voting on shares | Click here to vote |
Key Management of Theravance Biopharma Inc.
Name | Title |
|---|---|
Mr. Brett A. Grimaud Esq. | Senior VP, General Counsel & Secretary |
Ms. Stacy L. Pryce | Senior VP & Chief Strategy Officer |
Mr. Rick E. Winningham M.B.A. | CEO & Director |
Ms. Rhonda F. Farnum | Chief Business Officer and Senior VP of Commercial & Medical Affairs |
Dr. Aine Miller Ph.D. | Senior VP of Development & Head of Ireland Office |
Mr. Stuart Knight | Senior VP of IT&I and Chief Information Officer |
FAQs
What is Theravance Biopharma Inc. share price today?
Theravance Biopharma Inc. share price today is $16.93 as on at the close of the market. Theravance Biopharma Inc. share today touched a day high of $17.02 and a low of $16.94.
What is the 52 week high and 52 week low for Theravance Biopharma Inc. share?
Theravance Biopharma Inc. share touched a 52 week high of $21.03 on and a 52 week low of $10.82 on . Theravance Biopharma Inc. stock price today i.e. is closed at $16.93,which is 19.50% down from its 52 week high and 56.44% up from its 52 week low.
What is Theravance Biopharma Inc.'s market capitalisation today?
Theravance Biopharma Inc. market capitalisation is $0.00T as on .
How to invest in Theravance Biopharma Inc. Stock (TBPH) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Theravance Biopharma Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Theravance Biopharma Inc. Shares that will get you 0.0886 shares as per Theravance Biopharma Inc. share price of $16.93 per share as on July 3, 2026 at 8:45 am IST.
What is the minimum amount required to buy Theravance Biopharma Inc. Stock (TBPH) from India?
Indian investors can start investing in Theravance Biopharma Inc. (TBPH) shares with as little as ₹95.2 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹952.00 in Theravance Biopharma Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Theravance Biopharma Inc. share’s latest price of $16.93 as on July 3, 2026 at 8:45 am IST, you will get 0.5907 shares of Theravance Biopharma Inc.. Learn more about
fractional shares .
What are the returns that Theravance Biopharma Inc. has given to Indian investors in the last 5 years?
Theravance Biopharma Inc. stock has given 17.81% share price returns and 28.17% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?